Effect of kidney transplantation on outcomes among patients with hepatitis C.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1681/ASN.2010060668PMID 21546575PMCID PMC3103735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kidney Disease: Improving Global Outcomes

  2009cited by this paper
• KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.

  2008cited by this paper
• KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease

  2008cited by this paper
• Impact of Immunosuppressive Regimen on Survival of Kidney Transplant Recipients With Hepatitis C

  2008cited by this paper
• Hepatitis C virus infection and the prevalence of renal insufficiency.

  2007cited by this paper
• Hepatitis C Virus Infection and Kidney Transplantation: Predictors of Patient and Graft Survival

  2007cited by this paper
• Peginterferon and ribavirin for chronic hepatitis C.

  2006cited by this paper
• Hepatitis C virus and death risk in hemodialysis patients.

  2006cited by this paper
• Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey.

  2006cited by this paper
• A Randomized Long-Term Trial of Tacrolimus/Sirolimus versus Tacrolimums/Mycophenolate versus Cyclosporine/Sirolimus in Renal Transplantation: Three-Year Analysis

  2006cited by this paper
• Hepatitis C Virus Antibody Status and Survival After Renal Transplantation: Meta‐Analysis of Observational Studies

  2005cited by this paper
• Natural History of Hepatitis C Virus‐Related Liver Fibrosis After Renal Transplantation

  2005cited by this paper
• Outcome of Hepatitis C Virus‐Infected Kidney Transplant Candidates Who Remain on the Waiting List

  2005cited by this paper
• Meta‐analysis: effect of hepatitis C virus infection on mortality in dialysis

  2004cited by this paper
• The Statistical Analysis of Failure Time Data

  2003cited by this paper
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection

  2003cited by this paper
• Natural history of chronic hepatitis C

  2002cited by this paper
• Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

  2002cited by this paper
• Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362].

  2002cited by this paper
• A comprehensive study of the association between hepatitis C virus and glomerulopathy.

  2002cited by this paper
• Severe evolution of chronic hepatitis C in renal transplantation: a case control study.

  2002cited by this paper
• Hepatitis C virus infection in renal failure patients in the absence of anti‐hepatitis C virus antibodies

  2002cited by this paper
• Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection.

  2002cited by this paper
• Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients1

  2002cited by this paper
• Hepatitis C Virus Seropositivity at the Time of Renal Transplantation in the United States: Associated Factors and Patient Survival

  2001cited by this paper
• Hepatitis C virus infection.

  2001cited by this paper
• Anti–Interleukin‐2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation

  2001cited by this paper
• Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years

  2000cited by this paper
• Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome

  2000cited by this paper
• COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS , PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION , AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT

  2000cited by this paper
• Histopathological features of hepatitis C in renal transplant candidates [see comment].

  2000cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

  1999cited by this paper
• Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

  1999cited by this paper
• Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients

  1999cited by this paper
• Comparison of the enzyme‐linked immunosorbant assay III, recombinant immunoblot third generation assay, and polymerase chain reaction method in the detection of hepatitis C virus infection in Haemodialysis patients

  1999cited by this paper
• Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation

  1999cited by this paper
• Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis.

  1998cited by this paper
• Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients.

  1998cited by this paper
• Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

  1998cited by this paper
• Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.

  1998cited by this paper
• Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

  1998cited by this paper
• Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years.

  1998cited by this paper
• Risk of death among chronic dialysis patients infected with hepatitis C virus.

  1998cited by this paper
• Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

  1998cited by this paper
• Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease1

  1998cited by this paper
• The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients.

  1997cited by this paper
• Hepatitis C virus infection in dialysis and renal transplantation.

  1997cited by this paper
• An algorithm for the grading of activity in chronic hepatitis C

  1996cited by this paper
• Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations

  1995cited by this paper
• Transient effects in the Cox proportional hazards regression model.

  1995cited by this paper
• THE IMPACT OF PRETRANSPLANTATION HEPATITIS C INFECTION ON THE OUTCOME OF RENAL TRANSPLANTATION

  1995cited by this paper
• Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

  1993cited by this paper
• Membranoproliferative glomerulonephritis associated with hepatitis C virus infection.

  1993cited by this paper
• Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications.

  1993cited by this paper
• Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus.

  1993cited by this paper
• Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.

  1993cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper
• Nephrology Dialysis Transplantation Hepatitis C Virus Infection and Acute or Chronic Glomerulonephritis: an Epidemiological and Clinical Appraisal

  year unknowncited by this paper

• The Effect of Anti-Viral Treatment of HCV Infection on Outcomes of Renal Transplant Patients with Chronic HCV Infection: A Real-World Cohort Study

  2025cites this paper
• Repeat kidney transplantation in a patient with type 1 diabetes mellitus and chronic pyelonephritis: a clinical case

  2025cites this paper
• High risk of hepatic complications in kidney transplantation with chronic hepatitis C virus infection

  2025influential citation
• The Landscape of Hepatitis C Virus Infection in Pediatric Kidney Transplantation.

  2025cites this paper
• Outcomes after kidney transplant alone in patients with cirrhosis—A case‐control study

  2024cites this paper
• Kidney transplant recipient with history of HIV, HBV, and past HCV infection

  2024cites this paper
• Age-modified risk factors for mortality of non-elderly adult kidney transplant recipients: a retrospective database analysis

  2024cites this paper
• The Importance Of Avoiding Time-Dependent Bias When Testing The Prognostic Value Of An Intervening Event - Two Acute Cellular Rejection Examples In Intestinal Transplantation.

  2023cites this paper
• KDIGO 2022 Clinical Practice Guideline FOR the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

  2022cites this paper
• Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis.

  2021cites this paper
• Hepatitis c virus and chronic kidney disease

  2020cites this paper
• Review: Evaluation and Management of the HIV/HCV Co-Infected Kidney or Liver Transplant Candidate

  2020cites this paper
• Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus.

  2020influential citation
• Successful Kidney Transplantation in a Recipient Coinfected with Hepatitis C Genotype 2 and HIV from a Donor Infected with Hepatitis C Genotype 1 in the Direct-Acting Antiviral Era

  2020cites this paper
• Hepatitis C : prevalence, risk factors and implications for screening

  2020cites this paper
• Hepatitis C in Chronic Kidney Disease - An Overview of the KDIGO Guideline.

  2020cites this paper
• Current state of kidney transplantation in patients with HIV, hepatitis C, and hepatitis B infection

  2020cites this paper
• Recomendaciones para el tratamiento de la Hepatitis Crónica por Virus C en pacientes con insuficiencia renal crónica, en diálisis o trasplantados renales. Indicaciones de tratamiento 2018

  2019cites this paper
• Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre‐ and post‐direct‐acting antiviral therapy eras: 10‐Year single center experience

  2019cites this paper
• Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.

  2019cites this paper
• Highly effective treatment response and well tolerability by all oral direct acting antivirals for chronic hepatitis C patients post organ transplantation

  2019cites this paper
• Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection

  2019cites this paper
• Hepatitis C and kidney transplant: The eradication time of the virus has arrived

  2019cites this paper
• Non-immunological complications following kidney transplantation

  2019cites this paper
• Hepatitis C and kidney transplant: The eradication time of the virus has arrived.

  2019cites this paper
• KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

  2019influential citation
• Erratum to “Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients”

  2019cites this paper
• Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients

  2019cites this paper
• Hepatitis C in Patients on Hemodialysis

  2018cites this paper
• Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy

  2018cites this paper
• Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients

  2018cites this paper
• Population level outcomes and cost‐effectiveness of hepatitis C treatment pre‐ vs postkidney transplantation

  2018cites this paper
• Direct-Acting Antiviral Hepatitis C Therapy in Patients with Chronic Renal Failure

  2018cites this paper
• Management and treatment of the HCV‐infected kidney transplant patient

  2018influential citation
• Modulation of maintenance immunosuppression during infection in renal transplant recipients

  2018cites this paper
• KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

  2018influential citation
• Timing of hepatitis C virus infection treatment in kidney transplant candidates

  2018cites this paper
• Treatment and management options for the hepatitis C virus infected kidney transplant candidate

  2018cites this paper
• Management of Hepatitis C Infection in Kidney Transplantation Candidates and Recipients

  2018cites this paper
• Hepatitis C treatment in kidney transplant recipients: the need for sustained vigilance after sustained viral response

  2018cites this paper
• Unexpected donor‐derived infectious transmissions by kidney transplantation: A systematic review

  2018cites this paper
• Infection in Renal Transplant Recipients

  2018cites this paper
• LIJEČENJE PEGILIRANIM INTERFERONOM PRIJE TRANSPLANTACIJE POBOLJŠAVA TRANSPLANTACIJSKI ISHOD U DIJALIZIRANIH BOLESNIKA INFICIRANIH VIRUSOM HEPATITISA C

  2018cites this paper
• Successful outcome of transplanting a kidney from a HCV-positive deceased donor into a HCV-negative recipient

  2018cites this paper
• Use of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Virus Infection in the Perspective of Kidney Transplantation

  2017cites this paper
• Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories

  2017cites this paper
• HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs

  2017cites this paper
• Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis.

  2017cites this paper
• Successful Recovery of Acute Renal Transplant Failure in Recurrent Hepatitis C Virus–Associated Membranoproliferative Glomerulonephritis

  2017cites this paper
• Hepatitis C infection in renal transplantation: pathogenesis, current impact and emerging trends

  2017cites this paper
• Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation

  2017cites this paper
• Safety and efficacy of current direct‐acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV‐TARGET study

  2017influential citation
• Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus

  2017cites this paper
• Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-up

  2017cites this paper
• Jacobs Journal of Nephrology and Urology Induction with Thymoglobulin in High-Risk Renal Transplant Patients; Beauty and the Beast

  2017cites this paper
• Hepatitis B and C in Kidney Transplantation

  2017influential citation
• Antiviral treatment of hepatitis C in renal transplant patients - safety issues

  2017cites this paper
• Effective Treatment With Daclatasvir and Asunaprevir in Kidney Transplant Patients Infected With Hepatitis C Virus: A Report of Two Cases.

  2017cites this paper
• Use of HCV+ Donors Does Not Affect HCV Clearance With Directly Acting Antiviral Therapy But Shortens the Wait Time to Kidney Transplantation

  2017cites this paper
• Kidney Transplantation in Cirrhotic Patients

  2017cites this paper
• Long-term outcomes of hepatitis C virus infected renal allograft recipients

  2017cites this paper
• Prognostic immune markers for chronic allograft injury inrenal transplant recipients

  2017cites this paper
• Kidney Transplantation in the Hepatitis C Infected Recipient

  2017cites this paper
• Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis?

  2017cites this paper
• Management of Chronic Hepatitis C in End-stage Renal Disease.

  2017cites this paper
• Transplantation of kidneys from hepatitis C‐positive donors into hepatitis C virus‐infected recipients followed by early initiation of direct acting antiviral therapy: a single‐center retrospective study

  2017cites this paper
• Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease

  2017cites this paper
• Pancreas transplantation in unconventional recipients

  2016cites this paper
• Successful Treatment of a Hepatitis C–Positive Patient Who Received Kidney Transplant From a Hepatitis C–Positive Donor

  2016cites this paper
• Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.

  2016cites this paper
• Long‐term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the U.S. transplant registry

  2016cites this paper
• Hepatitis C Virus Infection in Chronic Kidney Disease.

  2016cites this paper
• Pretransplant Hepatitis B Viral Infection Increases Risk of Death After Kidney Transplantation

  2016cites this paper
• Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection

  2016cites this paper
• Anti-hepatitis C virus drugs and kidney

  2016cites this paper
• Increased risk of hepatic complications in kidney transplantation with chronic virus hepatitis infection: A nationwide population-based cohort study

  2016cites this paper
• Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon.

  2016cites this paper
• Challenges in Special Populations: HIV/HCV Coinfection, Liver Transplantation and Patients with End-Stage Renal Disease

  2016cites this paper
• Outcomes of Lung Transplantation in Recipients With Hepatitis C Virus Infection

  2016cites this paper
• Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct‐Acting Antiviral Agents

  2016cites this paper
• Direct‐Acting Antiviral Agents for the Hepatitis C Virus‐Infected Chronic Kidney Disease Population: The Dawn of a New Era

  2016cites this paper
• Hepatitis C und Nierenerkrankungen

  2016cites this paper
• Sofosbuvir‐based regimens for the treatment of hepatitis C virus in patients who underwent lung transplant: case series and review of the literature

  2016cites this paper
• Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus–infected patients with chronic kidney disease and end‐stage renal disease

  2016cites this paper
• Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis

  2016cites this paper
• Kidney Transplantation Threshold in Patients With Hepatitis C: A Decision Analysis Model

  2015cites this paper
• Hepatitis C und Nierentransplantation

  2015cites this paper
• Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV‐decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list

  2015cites this paper
• Impact of Hepatitis C on Survival in Dialysis : Liver-Related and Cardiovascular Mortality

  2015cites this paper
• Hepatitis C and its impact on renal transplantation

  2015cites this paper
• Novel Hepatitis C Treatment and the Impact on Kidney Transplantation.

  2015influential citation
• Management of patients with hepatitis C infection and renal disease.

  2015cites this paper
• The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.

  2015cites this paper
• Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review

  2015cites this paper
• The Challenges and Promise of HIV-Infected Donors for Solid Organ Transplantation

  2015cites this paper
• Hepatitis C infection in hemodialysis patients: A review.

  2015cites this paper
• Hepatitis C and kidney disease: An overview and approach to management.

  2015cites this paper
• Management of hepatitis C infection among patients with renal failure.

  2015cites this paper
• Evolution of treatment of chronic hepatitis C virus infection by directly acting anti-viral therapeutics: A glimmer of hope

  2015cites this paper
• Moderator's view: Pretransplant weight loss in dialysis patients: cum grano salis.

  2015cites this paper